Stockhub

Nanexa AB: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 August 2022

  • curprev 05:5905:59, 16 August 2022 >Paris 487 bytes +487 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden. == References and notes == Category:Thesis..."
Retrieved from "https://stockhub.co/research/Nanexa_AB"